Fungal Pathogens Flourish in the Pandemic’s Shadow

The World Health Organization’s first ever fungal priority pathogens list highlights the growing threat of fungal diseases and antifungal resistance.

Written byChristie Wilcox, PhD
| 3 min read
Microscope visualization of Candida albicans in an esophageal sample from a rhesus monkey with thrush
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In a new list of fungal “priority pathogens,” the World Health Organization identifies 19 of these often-overlooked microbes that pose the greatest threat to human health. The report, released today (October 25), highlights the fact that “fungal infections are growing, and are ever more resistant to treatments, becoming a public health concern worldwide,” says Hanan Balkhy, the WHO Assistant Director-General for antimicrobial resistance, in a statement. The organization previously compiled similar lists for viruses and bacteria.

More than 150 million severe fungal infections are estimated to occur annually, resulting in approximately 1.7 million deaths. But those numbers are based on incomplete data, which is why the report “aims to focus and drive further research and policy interventions to strengthen the global response to fungal infections and antifungal resistance.” For instance, fungal infections currently receive less than 1.5 percent of all infectious disease research funding, the authors note. The University of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies